
MOSCOW (Reuters) -A Russian Soyuz MS-28 spacecraft with two Russian cosmonauts and one NASA astronaut on board successfully docked with the International Space Station on Thursday, Russian space agency Roscosmos said.
But the agency later reported that the launch pad at the Baikonur Cosmodrome in Kazakhstan had sustained damage from the launch. It said the damage would be quickly repaired.
The Soyuz 2.1a rocket lifted off from the Baikonur Cosmodrome at 12:28 p.m. Moscow time (0928 GMT).
Late on Thursday, Russian news agencies quoted Roscosmos as saying the launch had taken place without incident, but damage was observed after an inspection of the launch area.
"Damage to a number of elements of the launch pad was detected. An assessment of the state of the launch complex is being conducted now," the agencies quoted Roscosmos as saying.
"All the necessary reserve elements are there to restore it and the damage will be eliminated very soon."
It said the crew was on board the station and in good health.
(Reporting by Anastasia Lyrchikova; Writing by Marina Bobrova; Editing by Andrew Osborn, Ron Popeski and Bill Berkrot)
LATEST POSTS
- 1
Toddler given just 3 years to live after strange symptoms makes full recovery - 2
Iran war fuels fears of new inflation wave among German consumers - 3
Tatiana Schlossberg's diagnosis puts spotlight on leukemia: What to know - 4
Woman gives birth on roadside after hospital allegedly sent her home: Family - 5
Why screening for the deadliest cancer in the U.S. misses most cases
A definitive Manual for the 5 Off-road Bicycles Available
Dick Van Dyke shares his secrets to longevity as he turns 100
The most effective method to Refresh the Infotainment Framework in the Volvo XC40
Find Your Ideal Tea: Six Particular Assortments
5 Great Home Remodel Administrations With Green Arrangements In 2024
Cyprus: War-related tourism concerns and climate change efforts
Excursion to Different Universes: the Top Sci-fi Motion pictures Ever
We analyzed Philly street scenes and identified signs of gentrification using machine learning trained on longtime residents’ observations
Merck sees over $5 billion opportunity in Cidara's experimental flu drug













